Cargando…
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology
BACKGROUND: Breast cancer is the most common malignancy to spread to the orbit and periorbit, and the invasive lobular carcinoma (ILC) histologic subtype of breast cancer has been reported to form these ophthalmic metastases (OM) more frequently than invasive ductal carcinomas (IDC). We herein repor...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318761/ https://www.ncbi.nlm.nih.gov/pubmed/32586354 http://dx.doi.org/10.1186/s13058-020-01309-3 |
_version_ | 1783550927507030016 |
---|---|
author | Blohmer, Martin Zhu, Li Atkinson, Jennifer M. Beriwal, Sushil Rodríguez-López, Joshua L. Rosenzweig, Margaret Brufsky, Adam M. Tseng, George Lucas, Peter C. Lee, Adrian V. Oesterreich, Steffi Jankowitz, Rachel C. |
author_facet | Blohmer, Martin Zhu, Li Atkinson, Jennifer M. Beriwal, Sushil Rodríguez-López, Joshua L. Rosenzweig, Margaret Brufsky, Adam M. Tseng, George Lucas, Peter C. Lee, Adrian V. Oesterreich, Steffi Jankowitz, Rachel C. |
author_sort | Blohmer, Martin |
collection | PubMed |
description | BACKGROUND: Breast cancer is the most common malignancy to spread to the orbit and periorbit, and the invasive lobular carcinoma (ILC) histologic subtype of breast cancer has been reported to form these ophthalmic metastases (OM) more frequently than invasive ductal carcinomas (IDC). We herein report our single academic institution experience with breast cancer OM with respect to anatomical presentation, histology (lobular vs. ductal), treatment, and survival. METHODS: We employed the natural language processing platform, TIES (Text Information Extraction System), to search 2.3 million de-identified patient pathology and radiology records at our institution in order to identify patients with OM secondary to breast cancer. We then compared the resultant cohort, the “OM cohort,” to two other representative metastatic breast cancer patient (MBC) databases from our institution. Histological analysis of selected patients was performed. RESULTS: Our TIES search and manual refinement ultimately identified 28 patients who were diagnosed with breast cancer between 1995 and 2016 that subsequently developed OM. Median age at diagnosis was 54 (range 28–77) years of age. ER, PR, and HER2 status from the 28 patients with OM did not differ from other patients with MBC from our institution. The relative proportion of patients with ILC was significantly higher in the OM cohort (32.1%) than in other MBC patients in our institution (11.3%, p = 0.007). Median time to first OM in the OM cohort was 46.7 months, and OM were the second most frequent first metastases after bony metastases. After diagnosis of the first distant metastasis of any kind, median survival of patients with ILC (21.4 months) was significantly shorter than that of patients with IDC (55.3 months, p = 0.03). Nine patients developed bilateral OM. We observed a significant co-occurrence of OM and central nervous system metastases (p = 0.0053). The histological analysis revealed an interesting case in which the primary tumor was of a mixed ILC/IDC subtype, while only ILC was present in the OM. CONCLUSIONS: OM from breast cancer are illustrative of the difference in metastatic behavior of ILC versus IDC and should be considered when treating patients with ILC, especially in those with complaints of visual acuity changes. |
format | Online Article Text |
id | pubmed-7318761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73187612020-06-29 Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology Blohmer, Martin Zhu, Li Atkinson, Jennifer M. Beriwal, Sushil Rodríguez-López, Joshua L. Rosenzweig, Margaret Brufsky, Adam M. Tseng, George Lucas, Peter C. Lee, Adrian V. Oesterreich, Steffi Jankowitz, Rachel C. Breast Cancer Res Research Article BACKGROUND: Breast cancer is the most common malignancy to spread to the orbit and periorbit, and the invasive lobular carcinoma (ILC) histologic subtype of breast cancer has been reported to form these ophthalmic metastases (OM) more frequently than invasive ductal carcinomas (IDC). We herein report our single academic institution experience with breast cancer OM with respect to anatomical presentation, histology (lobular vs. ductal), treatment, and survival. METHODS: We employed the natural language processing platform, TIES (Text Information Extraction System), to search 2.3 million de-identified patient pathology and radiology records at our institution in order to identify patients with OM secondary to breast cancer. We then compared the resultant cohort, the “OM cohort,” to two other representative metastatic breast cancer patient (MBC) databases from our institution. Histological analysis of selected patients was performed. RESULTS: Our TIES search and manual refinement ultimately identified 28 patients who were diagnosed with breast cancer between 1995 and 2016 that subsequently developed OM. Median age at diagnosis was 54 (range 28–77) years of age. ER, PR, and HER2 status from the 28 patients with OM did not differ from other patients with MBC from our institution. The relative proportion of patients with ILC was significantly higher in the OM cohort (32.1%) than in other MBC patients in our institution (11.3%, p = 0.007). Median time to first OM in the OM cohort was 46.7 months, and OM were the second most frequent first metastases after bony metastases. After diagnosis of the first distant metastasis of any kind, median survival of patients with ILC (21.4 months) was significantly shorter than that of patients with IDC (55.3 months, p = 0.03). Nine patients developed bilateral OM. We observed a significant co-occurrence of OM and central nervous system metastases (p = 0.0053). The histological analysis revealed an interesting case in which the primary tumor was of a mixed ILC/IDC subtype, while only ILC was present in the OM. CONCLUSIONS: OM from breast cancer are illustrative of the difference in metastatic behavior of ILC versus IDC and should be considered when treating patients with ILC, especially in those with complaints of visual acuity changes. BioMed Central 2020-06-26 2020 /pmc/articles/PMC7318761/ /pubmed/32586354 http://dx.doi.org/10.1186/s13058-020-01309-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Blohmer, Martin Zhu, Li Atkinson, Jennifer M. Beriwal, Sushil Rodríguez-López, Joshua L. Rosenzweig, Margaret Brufsky, Adam M. Tseng, George Lucas, Peter C. Lee, Adrian V. Oesterreich, Steffi Jankowitz, Rachel C. Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology |
title | Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology |
title_full | Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology |
title_fullStr | Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology |
title_full_unstemmed | Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology |
title_short | Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology |
title_sort | patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318761/ https://www.ncbi.nlm.nih.gov/pubmed/32586354 http://dx.doi.org/10.1186/s13058-020-01309-3 |
work_keys_str_mv | AT blohmermartin patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT zhuli patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT atkinsonjenniferm patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT beriwalsushil patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT rodriguezlopezjoshual patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT rosenzweigmargaret patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT brufskyadamm patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT tsenggeorge patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT lucaspeterc patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT leeadrianv patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT oesterreichsteffi patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology AT jankowitzrachelc patienttreatmentandoutcomeafterbreastcancerorbitalandperiorbitalmetastasesacomprehensivecaseseriesincludinganalysisoflobularversusductaltumorhistology |